Patents by Inventor David James Le Count

David James Le Count has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alkanolamine derivatives
    Patent number: 4059622
    Abstract: New 1-amino-3-(o-carbamoylalkoxyphenoxy)propan-2-ol derivatives, for example 1-t-butylamino-3-(o-N-methylcarbamoylmethoxyphenoxy)propan-2-ol, processes for their manufacture and pharmaceutical compositions containing them. The compounds possess .beta.-adrenergic blocking activity and are useful in the treatment of heart diseases and other conditions in man.
    Type: Grant
    Filed: February 26, 1974
    Date of Patent: November 22, 1977
    Assignee: Imperial Chemical Industries Limited
    Inventors: David James Le Count, Christopher John Squire
  • Method for producing .beta.-adrenergic blockage with alkanolamine derivatives
    Patent number: 3959486
    Abstract: New 1-amino-3-carbamoylalkoxyphenoxypropan-2-ol derivatives, for example 1-t-butylamino-3-(o-N-methylcarbamoylmethoxyphenoxy)propane-2-ol, processes for their manufacture and pharmaceutical compositions containing them. The compounds possess .beta.-adrenergic blocking activity and are useful in the treatment of heart diseases and other conditions in man.
    Type: Grant
    Filed: January 7, 1974
    Date of Patent: May 25, 1976
    Assignee: Imperial Chemical Industries Limited
    Inventors: David James Le Count, Christopher John Squire
  • Alkanolamine derivatives for treating hypertension
    Patent number: 3934032
    Abstract: 1-(ELECTRONEGATIVELY-SUBSTITUTED-ALKYL- OR ALKENYLPHENOXY)-3-ALKYLAMINO-2-PROPANOL DERIVATIVES, FOR EXAMPLE 1-P-CARBAMOYLMETHYLPHENOXY-3-ISOPROPYLAMINO-2-PROPANOL, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM POSSESS .beta.-ADRENERGIC BLOCKING ACTIVITY AND ARE USEFUL IN THE TREATMENT OF HEART DISEASES AND OTHER COMPLAINTS IN MAN.
    Type: Grant
    Filed: April 15, 1974
    Date of Patent: January 20, 1976
    Assignee: Imperial Chemical Industries Limited
    Inventors: Arthur Michael Barrett, John Carter, Roy Hull, David James Le Count, Christopher John Squire